Terrence Keaney, MD
Dermatology · Washington, DCNPI 1902049489
Payments from drug & device makers
Across 1,006 payments — averaging $3426.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3.3M
- Merz North America, Inc.$99K
- Lilly USA, LLC$26K
- EPI Health, LLC$20K
- Dermira, Inc.$9K
- Solta Medical, A Division Of Bausch Health US, LLC$8K
- plus $15K from 18 others
Across 9 payments — averaging $869.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merz North America, Inc.$6K
- AbbVie$2K
What the payments were for
- Consulting fees$678,98261%
- Speaking & faculty fees$331,28530%
- Travel & lodging$87,2698%
- Food & beverage$22,1092%
- Education$2290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 767 | $3,270,248 |
| Merz North America, Inc. | 116 | $99,350 |
| Lilly USA, LLC | 31 | $25,925 |
| EPI Health, LLC | 5 | $19,584 |
| Dermira, Inc. | 9 | $8,523 |
| Solta Medical, A Division Of Bausch Health US, LLC | 8 | $7,818 |
| Sun Pharmaceutical Industries Inc. | 8 | $7,599 |
| Aclaris Therapeutics, Inc. | 8 | $4,608 |
| Taro Pharmaceuticals USA, Inc. | 1 | $1,665 |
| Galderma Laboratories, L.p. | 14 | $324 |
| Johnson & Johnson | 4 | $142 |
| Bristol Myers Squibb | 7 | $109 |
| Endo Pharmaceuticals Inc. | 2 | $108 |
| Almirall LLC | 5 | $103 |
| Novartis | 4 | $80 |
| Incyte Corporation | 3 | $67 |
| UCB, Inc. | 2 | $54 |
| Arcutis Biotherapeutics, Inc. | 3 | $51 |
| Pfizer | 2 | $47 |
| Sanofi | 2 | $42 |
| LEO Pharma Inc. | 2 | $42 |
| Strata Skin Sciences, Inc. | 1 | $39 |
| Encore Dermatology Inc. | 1 | $20 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$296,900
- BOTOX COSMETIC$64,171
- XEOMIN$57,643
- OLUMIANT$23,600
- Rhofade$21,480
- Sitavig$19,500
- Cloderm$19,500
- Minolira 105mg$19,500
- Minolira 135mg$19,500
- QBREXZA$8,503
- THERMAGE FLX$7,641
- Clear & Brilliant$7,641
- Winlevi$3,000
- ESKATA$2,500
- ALLODERM$2,350
- ASCLERA$237
How this compares
$3,446,559 in reported general payments places this provider in the 95th percentile of 73 dermatology providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Washington
- Jonathan SilverbergWashington$5.1M
- Adam FriedmanWashington$2.2M
- Michael CardisWashington$618K
- Noelle SherberWashington$255K
- Candrice HeathWashington$212K
- Lynn McKinley-GrantWashington$175K
- Yolanda HolmesWashington$171K
- Cheri FreyWashington$147K
- Maral SkelseyWashington$132K
- Agnes ChangWashington$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.